2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee
FDA Comment Number : EC12
Submitter : Dr. Carol Tamminga Date & Time: 08/30/2004 02:08:35
Organization : American College of Neuropsychopharmacology
Health Care Association
Category :
Issue Areas/Comments
GENERAL
GENERAL
ACNP COMMENTS ON SSRI USE IN ADOLESCENTS

Depression in youth is a serious disorder. It affects school, family and peer relationships, can lead to drug/alcohol abuse and suicide, and is recurrent, often leading to adult depression. Furthermore, depression itself impacts the developing brain. Allowing depression to go untreated significantly delays improvement, thereby increasing the likelihood of long-term negative outcomes.

(Full Comments Attached)